Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8430 per EA under NDC 62332063460. Its NADAC has been published 106 times since Aug 14, 2024.
FDA first approved this application on Jun 14, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332063460
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA215233FDA Approved
6/14/2024
TE Code
AB
On Market Since
6/14/2024
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 106 times since Aug 14, 2024, and over the history we have for it it has declined 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8430 per EA |
|---|---|
| All-time high | $2.1906 (Dec 11, 2024) |
| All-time low | $0.8430 (Aug 19, 2026) |
| 52-week high | $1.1670 |
| 52-week low | $0.8430 |
| Median price | $1.2390 |
| Average price | $1.4270 |
| Largest weekly change | -11.0% (Aug 20, 2025) |
| Weeks tracked | 106 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.8430 per EA (NDC 62332063460), effective Aug 19, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 58.9%. It has been tracked across 106 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Aug 14, 2024, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8430 (Aug 19, 2026) to a high of $2.1906 (Dec 11, 2024), with a median of $1.2390 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DABIGATRAN ETEXILATE 75 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 62332063460) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.